BioTelemetry, Inc. Reports Fourth Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
BioTelemetry (BEAT) Tops Q4 EPS by 1c
February 26, 2020 4:27 PM ESTBioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.48, $0.01 better than the analyst estimate of $0.47. Revenue for the quarter came in at $112 million versus the consensus estimate of $110.18 million.
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented:Our fourth quarter capped off a strong year for BioTelemetry, highlighted by our highest quarterly revenue and adjusted EBITDA in company history. These results came in... More
